Skip to content

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain diseases and disorders of the central nervous system. Launched in 2021 by the University of California, San Francisco, UC Berkeley, Genentech — a member of the Roche group — and Roche Holding AG, the ATN seeks to accelerate the development of new therapies for a broad range of brain and central nervous system conditions.

With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco and the University of Washington have launched the Weill Neurohub, an innovative research network that will forge and nurture new collaborations between neuroscientists and researchers working in an array of other disciplines — including engineering, computer science, physics, chemistry and mathematics — to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.

Gyroscopes measure rotation in everyday technologies, from unmanned aerial vehicles to cell phone screen stabilizers. Though many animals can move with more precision and accuracy than our best-engineered aircraft and technologies, gyroscopes are rarely found in nature. Scientists know of just one group of insects, the group including flies, that has something that behaves like a gyroscope — sensors called halteres, clublike structures that evolved from wings. Halteres provide information about the rotation of the body during flight, which helps…